Syneron Medical
An Israeli medical-device company known for aesthetic laser, light, radiofrequency, and ultrasound systems used in dermatology and cosmetic procedures, also known as Syneron Candela.
Last updated October 30, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Syneron Medical Ltd., also known as Syneron Candela, is an Israeli medical-device company that develops and markets equipment for aesthetic medicine, dermatology, and cosmetic surgery. Its product focus has included systems for hair removal, wrinkle reduction, skin tightening, pigmentation treatment, vascular treatment, and related dermatological procedures. The company’s technologies have included laser, intense pulsed light, radiofrequency, and ultrasound modalities, giving it a portfolio that spans several forms of energy-based treatment rather than a single device category. The company was established in 2000 by Shimon Eckhouse, who had previously founded Lumenis, another medical-device business active in aesthetic and surgical technologies. Syneron’s formation placed it in a competitive field serving dermatologists, plastic surgeons, cosmetic physicians, and other professional users. Its commercial model centered on the development, manufacture, and international sale of capital equipment used by clinics and medical practices, rather than on consumer retail products. Syneron’s early corporate history was affected by litigation with Lumenis. In 2002, Lumenis sued Eckhouse and Syneron, alleging theft of trade secrets. The dispute was resolved in 2004. Under the reported settlement, Syneron paid Lumenis $1.5 million and agreed to royalty obligations. The episode is a significant part of the company’s history because it concerned intellectual-property boundaries at a formative stage of Syneron’s development. The global financial crisis of 2008 disrupted the company’s growth trajectory. As the business encountered difficulty sustaining its earlier expansion, it pursued a major consolidation strategy by acquiring Candela. Candela was an established supplier of aesthetic equipment serving dermatologists and plastic surgeons, and the combination brought together two businesses with overlapping but complementary product portfolios and customer relationships. Following the transaction, the combined business became widely known as Syneron Candela. In 2017, Apax Partners acquired Syneron. The transaction took the company private and changed its ownership structure from a publicly traded medical-device business to a private-equity-owned company. The Syneron Candela identity continued to be associated with professional aesthetic and dermatological equipment after the acquisition. Public reference material identifies the business as a supplier of systems for procedures such as hair removal and wrinkle treatment, while the broader portfolio has covered multiple energy-based applications. Syneron Medical should therefore be understood primarily as a professional medical-technology and aesthetic-device brand. Its market positioning is based on providing clinical practices with equipment platforms for non-invasive or minimally invasive cosmetic and dermatological procedures. The available reference material does not establish a separate consumer-facing business, a current public listing, or a definitive present-day executive roster. It also does not provide sufficient evidence to describe current ownership operations in more detail than the association with Apax Partners.
History
Syneron Medical was founded in Israel in 2000 by Shimon Eckhouse. Eckhouse had previously founded Lumenis in 1991, a company involved in medical and aesthetic devices, and Syneron emerged in the same broad technological and commercial field. From its beginning, Syneron concentrated on professional equipment for aesthetic medicine and dermatology, developing and marketing systems intended for procedures including hair removal, wrinkle treatment, skin rejuvenation, and other cosmetic applications. The company’s early development was accompanied by an intellectual-property dispute. In 2002, Lumenis sued Syneron and Eckhouse, alleging that trade secrets had been taken. The dispute was ultimately resolved in 2004. The reported settlement required Syneron to pay Lumenis $1.5 million and to make royalty payments. This litigation became an important event in Syneron’s corporate history because it involved the company’s founder and its relationship to a previous employer operating in a closely related technology market. Syneron expanded in a sector serving dermatologists, plastic surgeons, and other professional medical users. Its portfolio included several energy-based technologies, including laser, light, radiofrequency, and ultrasound systems. Such equipment is generally sold as capital equipment to clinics and practices, where it supports procedures such as hair removal, wrinkle reduction, pigmentation treatment, skin tightening, and related aesthetic interventions. The financial crisis that began in 2008 affected the company’s ability to maintain its previous growth rate. In response to the changing market environment and the need for greater scale, Syneron acquired Candela. Candela was also known for aesthetic equipment supplied to dermatologists and plastic surgeons. The transaction combined businesses with related customers and product categories and led to the broader Syneron Candela identity. The combination allowed the company to present a more extensive portfolio of professional aesthetic systems across multiple treatment modalities. In 2017, Apax Partners acquired Syneron. The acquisition took the company private and marked a major change in its corporate structure. Before the transaction, Syneron had operated as a publicly traded medical-device company; afterward, it became associated with private-equity ownership. The business continued to be identified with the Syneron Candela name and with professional aesthetic and dermatological equipment. The available reference material does not establish a complete account of later corporate developments, a current executive team, or the precise legal relationship among Syneron Medical, Syneron Candela, and Apax Partners. It does, however, support a clear description of Syneron Medical as an Israeli-origin medical-technology business focused on professional energy-based devices for aesthetic and dermatological procedures. Its history is shaped by its 2000 founding, the 2002–2004 trade-secret litigation, the acquisition of Candela following the 2008 crisis, and the 2017 take-private transaction.
- 2017
Apax Partners takes Syneron private
[1]Apax Partners acquires Syneron, changing the company from a publicly traded business to a privately owned enterprise.
- 2008
Financial crisis changes growth strategy
[1]The global financial crisis weakens Syneron’s ability to sustain its prior growth and contributes to a subsequent consolidation strategy.
- 2004
Trade-secret litigation is settled
[1]The dispute with Lumenis is resolved through a settlement reported to include a $1.5 million payment and royalty obligations.
- 2002
Lumenis initiates trade-secret litigation
[1]Lumenis sues Syneron and Eckhouse over alleged theft of trade secrets.
- 2000
Syneron Medical is founded
[1]Shimon Eckhouse establishes Syneron Medical in Israel as a developer and marketer of professional aesthetic and medical devices.
- 1991
Shimon Eckhouse founds Lumenis
[1]Before establishing Syneron, Shimon Eckhouse founded Lumenis, a medical-device company active in related aesthetic and surgical technologies.
Products and positioning
A professional aesthetic-medicine and dermatology equipment provider offering energy-based platforms for hair removal, skin rejuvenation, wrinkle treatment, pigmentation and vascular applications, and skin tightening.
Medical and aesthetic laser devices
Aesthetic laser systems
Syneron’s core product area consists of professional laser platforms used in aesthetic and dermatological procedures. Applications described for the company include hair removal, wrinkle treatment, skin rejuvenation, and other cosmetic treatments. These systems are designed for clinical users such as dermatologists, plastic surgeons, and aesthetic practices rather than ordinary consumer use.
Energy-based aesthetic devices
Radiofrequency devices
Radiofrequency equipment forms part of the company’s broader energy-based portfolio. Such systems are associated with professional aesthetic applications including skin tightening and rejuvenation. The available reference material confirms the technology category but does not provide a complete model-by-model history or current product catalog.
Energy-based aesthetic devices
Ultrasound devices
Ultrasound systems are another technology category associated with Syneron’s aesthetic and medical-device activities. They broaden the company’s offering beyond laser and light-based equipment and support its positioning as a multi-modality supplier to professional treatment providers. Specific indications and model dates are not established by the supplied sources.
Aesthetic treatment system
elōs Plus
elōs Plus is identified in the existing brand dossier as a flagship offering associated with Syneron’s aesthetic-device portfolio. The supplied references do not provide sufficient detail to document its launch date, technical configuration, approved indications, or present availability.
Vascular and dermatological laser system
Vbeam
Vbeam is identified in the existing dossier among the brand’s flagship offerings. The supplied reference material does not provide enough information to establish the product’s specific ownership history, launch date, technical specifications, or current status within the Syneron Candela portfolio.
Aesthetic laser system
GentleMax Pro
GentleMax Pro is identified in the existing dossier as a flagship offering associated with the company. The available sources do not establish a detailed product history, launch year, current commercial status, or the exact corporate entity responsible for its present marketing.
Controversies
Brand decisions
2017
Apax Partners acquisition and take-private transactionM&ABackground
Syneron was operating as a publicly traded medical-device company before the transaction.
Action taken
Apax Partners acquired Syneron and took the company private.
Aftermath
The transaction changed Syneron’s ownership structure and associated the business with private-equity ownership.
- Acquisition of CandelaM&A
Background
After the 2008 financial crisis reduced Syneron’s ability to sustain its prior growth, the company pursued consolidation with another supplier of aesthetic equipment.
Action taken
Syneron acquired Candela, a business serving dermatologists and plastic surgeons with related aesthetic products.
Aftermath
The transaction combined complementary aesthetic-device portfolios and contributed to the Syneron Candela identity.
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/syneron-medical · Editorial policy · How profiles are compiled